Shares in Ceres Power shifted sharply lower this week, extending a punishing slide that has cut roughly 35% off the stock since late May, as the market continues to digest a heavily dilutive capital raise and a broader rotation out of speculative clean-energy names.
• 18 Million New Shares Flooded the Market at a Discount
Ceres placed 17.79 million new shares with institutional investors at 570p each, a 6.5% discount to the prior close of 609.5p.
Retail investors took up 180,000 more shares and directors subscribed for 31,051, bringing the total to 18 million new shares — equivalent to 9.2% of the existing share base. In plain terms, every existing shareholder's ownership stake shrank by nearly a tenth overnight, and the discounted price pulled the entire stock down toward the offer level.
• Oversubscription Signals Demand but Doesn't Erase the Dilution Math
The fundraising, led by Berenberg and UBS, was oversubscribed, reflecting continued investor interest in the company's fuel-cell technology. That is a confidence vote — but confidence doesn't change arithmetic. Following admission, Ceres now has 213.8 million voting shares in issue , up from roughly 196 million. At today's 367.60p, the market capitalisation sits near £786m, well below the ~£1bn it briefly touched. The company continues to report losses and negative cash flow , making per-share earnings dilution particularly painful since there are no profits to spread across the bigger base.
• The Cash Is Earmarked for Commercialisation, Not Survival
Ceres plans to use the net proceeds of roughly £100 million to accelerate commercial momentum for its fuel-cell technology, support partner expansion and reinforce its balance sheet.
The group has signed licensing agreements with large customers — Centrica and Doosan among them — and received its first royalty payment of just £110,000 in 2025.
Ceres already posts a 70% gross profit margin , but royalties must scale dramatically to justify the enlarged share count.
• A Wider Market Mood Shift Amplified the Selling
Part of the sell-off reflects a general shift by investors out of speculative stocks throughout June, driven in part by capital being redirected toward the SpaceX IPO.
Over the past year, the stock is still up roughly 374% , giving long-term holders a cushion — but for anyone who bought near the 873p peak, the question now is whether £100m in fresh funding can turn a licensing-stage company into a profit engine before patience runs out.